Company news
Heron Therapeutics, Inc. news in 2019
Heron Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.
Heron Therapeutics Announces Publication of the Mechanism of Action Data for HTX-011, a Dual-Acting Local Anesthetic Being Developed for Management of Postoperative Pain
December 15, 2019
Health Canada Grants Priority Review Status for Heron Therapeutics' New Drug Submission for HTX-011 for Management of Postoperative Pain
December 2, 2019
Heron Therapeutics to Present at the Evercore ISI HealthCONx Conference
November 25, 2019
Heron Therapeutics to Present at the Jefferies London Healthcare Conference
November 13, 2019
Heron Therapeutics to Present at the Stifel 2019 Healthcare Conference
November 12, 2019
Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2019 and Highlights Recent Corporate Updates
November 11, 2019
Heron Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for HTX-011 for Management of Postoperative Pain
October 27, 2019
Heron Announces FDA Approval of Supplemental New Drug Application to Expand CINVANTI® Label for Single-Dose Regimen for Patients Receiving Moderately Emetogenic Chemotherapy (MEC)
October 21, 2019
Heron Therapeutics Announces Proposed Public Offering of Common Stock
October 2, 2019
Heron Therapeutics Announces Pricing of Public Offering of Common Stock
October 2, 2019
Heron Announces Positive Topline Results from Phase 3b Clinical Study of HTX-011 in Total Knee Arthroplasty
October 1, 2019
Heron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Management of Postoperative Pain
September 30, 2019
Heron Therapeutics Appoints Stephen Davis to Board of Directors
September 30, 2019
Heron Therapeutics Appoints Kimberly Manhard to Board of Directors
September 30, 2019
Heron Therapeutics Announces Publication of Results from EPOCH 2, a Phase 3 Study of HTX-011 in Patients Undergoing Hernia Repair Surgery
August 19, 2019
Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2019 and Highlights Recent Corporate Updates
August 4, 2019
Heron Therapeutics to Present at 2019 JMP Securities Life Sciences Conference
June 12, 2019
Heron Therapeutics to Present at Jefferies 2019 Healthcare Conference
May 28, 2019
Heron Therapeutics Receives Complete Response Letter For HTX-011 For The Management Of Postoperative Pain
April 30, 2019
Heron Announces European Medicines Agency Validation of Marketing Authorisation Application for HTX-011 for Postoperative Pain Management
March 31, 2019
Decks in 2019
- Corporate Update (October 2019)
Corporate update · 46 slides · Oct 2, 2019
- Corporate Update (January 2019)
Corporate update · 71 slides · Jan 7, 2019